FIELD: chemistry.
SUBSTANCE: present invention relates to a kit for an immunogenic composition, and an immunogenic composition which contains a polynucleotide adjuvant composition together with an antigen (for example as a vaccine). The disclosed adjuvant compositions (versions) have special physical properties (for example molecular mass, concentration and pH), which meet requirements for a safe adjuvant for inducing intense immune response. The invention also relates to a method of preparing an immunogenic composition and using immunogenic adjuvant compositions, particularly for inducing immune response to an antigenic compound.
EFFECT: disclosed adjuvant compositions are safe and efficiently provide the desired immunogenic effect in humans.
25 cl, 2 dwg, 15 tbl, 16 ex
Title | Year | Author | Number |
---|---|---|---|
IMMUNOGENIC SUBSTANCES CONTAINING ADJUVANT OF POLYINOSINE ACID AND POLYCYTIDYLIC ACID | 2006 |
|
RU2462264C2 |
PHARMACEUTICAL COMPOSITION CONTAINING POLYNUCLEOTIDES, AND USE THEREOF FOR PREVENTING OR TREATING COVID-19 | 2021 |
|
RU2824489C1 |
RABIES COMPOSITION CONTAINING PIKA ADJUVANT | 2014 |
|
RU2678981C2 |
COMPOSITION CONTAINING PIC FOR CANCER TREATMENT | 2017 |
|
RU2728175C2 |
IMPROVED IMMUNOLOGICAL COMPOSITION | 2012 |
|
RU2664730C2 |
COMPLEX FOR ENHANCING IMMUNE RESPONSE | 2019 |
|
RU2779622C2 |
MICROPARTICLES FOR DELIVERY OF HETEROLOGOUS NUCLEIC ACIDS | 2001 |
|
RU2295954C2 |
PARAPOXVIRUS VECTOR CONTAINING RABIES VIRUS ANTIGEN | 2011 |
|
RU2545694C2 |
PHARMACEUTICAL COMPOSITION OF PATTERN-RECOGNISING RECEPTOR LIGANDS, METHODS FOR USING IT AS IMMUNOSTIMULANT FOR TREATING INFECTION CAUSED BY BACTERIAL AND VIRAL PATHOGENS, METHOD FOR USING IT AS ADJUVANT OF VACCINES | 2012 |
|
RU2497541C1 |
IMMUNOGENIC COMPOSITIONS OF Bordetella bronchiseptica | 2012 |
|
RU2554480C2 |
Authors
Dates
2010-03-10—Published
2005-06-08—Filed